Binnacle Investments Inc Pacira Bio Sciences, Inc. Transaction History
Binnacle Investments Inc
- $137 Billion
- Q1 2025
A detailed history of Binnacle Investments Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Binnacle Investments Inc holds 8 shares of PCRX stock, worth $206. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8Holding current value
$206% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PCRX
# of Institutions
264Shares Held
48.7MCall Options Held
853KPut Options Held
184K-
Black Rock Inc. New York, NY8.01MShares$207 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$135 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$58.3 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$57.8 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$52.9 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.18B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...